Dave Grayzel
Director/Board Member at AEROVATE THERAPEUTICS, INC.
Net worth: - $ as of 30/04/2024
Network origin in Dave Grayzel first degree
Entity | Entity type | Industry | |
---|---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.
91
| Private Company | Investment Managers | 91 |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.
70
| Non-Profit Organization | Hospital/Nursing Management | 70 |
Harvard Medical School
54
| College/University | Other Consumer Services | 54 |
Public Company | Pharmaceuticals: Major | 30 | |
Subsidiary | Biotechnology | 27 | |
Public Company | Pharmaceuticals: Major | 20 | |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA.
17
| Holding Company | Biotechnology | 17 |
Public Company | Biotechnology | 17 | |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA.
12
| Subsidiary | Biotechnology | 12 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts.
11
| Subsidiary | Investment Managers | 11 |
Subsidiary | Pharmaceuticals: Major | 7 | |
Tri-Institutional Therapeutics Discovery Institute, Inc.
Tri-Institutional Therapeutics Discovery Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Memorial Sloan Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute, Inc. is an American New York-based company that encourages the Tri-Institutional community to advance their biological discoveries to preclinical studies. The private company provides technical support for academic projects and offers a menu of services to translate research discoveries from bench to bedside. Tri-Institutional Therapeutics Discovery Institute achieves its mission by leveraging the infrastructure, staff, and intellectual capital of its academic and industry partners, as well as the generous support of philanthropists. The company was founded by David A. Scheinberg.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Arteaus Therapeutics LLC
Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA.
2
| Private Company | Biotechnology | 2 |
Delinea, Inc. (United States)
Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ.
2
| Subsidiary | Biotechnology | 2 |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dave Grayzel via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Memorial Sloan-Kettering Cancer Center (Investment Management)
Memorial Sloan-Kettering Cancer Center (Investment Management) Investment Trusts/Mutual FundsMiscellaneous Memorial Sloan-Kettering Cancer Center (Investment Management) (MSK-IM) is the investment management division of Memorial Sloan-Kettering Cancer Center, a non-profit organization headquartered in New York City. The firm was formed in 1960 to coordinate and guide the overall policy for Memorial Hospital and the Sloan Kettering Institute, and in 1980 these entities were unified into a single institution, with a single president and CEO. MSK-IM manages the investment portfolio of MSK. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Chief Operating Officer | |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman Founder Director/Board Member Corporate Officer/Principal Consultant / Advisor Chief Executive Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Consultant / Advisor Founder Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member Founder Private Equity Investor | |
Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Executive Officer Founder Consultant / Advisor | |
Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Navitor Pharmaceuticals, Inc.
Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Princeton University | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal Chief Executive Officer | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Chairman Corporate Officer/Principal Director/Board Member | |
TRANSLATE BIO, INC. | Biotechnology | Chairman Founder Director/Board Member Director/Board Member | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Director/Board Member Chief Operating Officer General Counsel | |
SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member Chief Operating Officer | |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Doctorate Degree Graduate Degree Masters Business Admin Graduate Degree | |
THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member | |
GENERATION BIO CO. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
Judo Bio, Inc.
Judo Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Judo Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. The company was founded in 2021 by Chelsea Place Johnson. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member Founder | |
Purdue University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
New England Venture Capital Association, Inc.
New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Investor Relations Contact Director/Board Member | |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal President | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member | |
Yale University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
VIGIL NEUROSCIENCE, INC. | Biotechnology | Chief Executive Officer Chairman Private Equity Investor | |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member Private Equity Investor | |
SYNLOGIC, INC. | Biotechnology | Chairman Director/Board Member Founder | |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member President Chief Tech/Sci/R&D Officer | |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
United States | 50 |
United Kingdom | 2 |
Sectoral
Health Technology | 35 |
Consumer Services | 10 |
Commercial Services | 5 |
Miscellaneous | 2 |
Finance | 2 |
Operational
Director/Board Member | 715 |
Corporate Officer/Principal | 270 |
Independent Dir/Board Member | 178 |
Chairman | 137 |
Chief Executive Officer | 108 |
Most connected contacts
Insiders | |
---|---|
Jean-Francois Formela | 47 |
Ed Mathers Mathers | 47 |
Anthony Evnin | 46 |
James Robinson | 42 |
Bruce Booth | 40 |
Christopher Lynch | 38 |
Ryan Moore | 38 |
Peter Barrett | 38 |
John Maraganore | 37 |
Kevin Bitterman | 36 |
Joshua Resnick | 36 |
Daniel Lynch | 32 |
Craig Thompson | 29 |
Maha Katabi | 28 |
Felix Baker | 28 |
- Stock Market
- Insiders
- Dave Grayzel
- Company connections